Thomas Hedner, & Jean Lycke. (2019). CRISPR/Cas9 system and gene editing tools: On patent rights, recent disputes and its potential commercial applicability in biotechnology and medicine. Stockholm Intellectual Property Law Review , 2(1), 12–23. https://doi.org/10.59625/siplr.v2i1.63298